Home › Funds › Point72 Asset Management › NRXP
Point72 Asset Management position in NRXP
NRX PHARMACEUTICALS INC · Health Care
Latest position (Q4 2025)15.98K sh
Reported value held$43.30K
Portfolio Weight0.00%
First reportedQ4 2025
Last changeNew
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 15.98K | $43.30K | New |
Other funds holding NRXP
- Balyasny Asset Management 893.86K sh · $3.66M · Q2 2026
- Vanguard Group 729.84K sh · $1.98M · Q4 2025
- UBS Group AG 423.12K sh · $1.73M · Q2 2026
- Geode Capital Management 314.66K sh · $1.29M · Q2 2026
- BlackRock Inc 220.46K sh · $901.68K · Q2 2026
- Marshall Wace 194.58K sh · $795.83K · Q2 2026
- Northern Trust Corp 62.95K sh · $257.47K · Q2 2026
- Morgan Stanley 40.90K sh · $167.28K · Q2 2026
- Renaissance Technologies 38.60K sh · $157.87K · Q2 2026
- Citadel Advisors 26.70K sh · $109.20K · Q2 2026
- Two Sigma Investments 26.43K sh · $108.09K · Q2 2026
- Millennium Management 12.30K sh · $50.33K · Q2 2026